
Aricept is a brand of donepezil, an acetylcholinesterase inhibitor. It reduces the breakdown of acetylcholine, a chemical that helps nerve cells communicate and is involved in memory and thinking.
| Feature | Details |
| Brand | Aricept |
| Active ingredient | Donepezil hydrochloride |
| Strength discussed | 10 mg |
| Form | Film-coated oral tablets |
| Main use | Symptoms of Alzheimer’s dementia |
The product discussed is Aricept 10 mg, 7 tablets. The expression “Aricept tab” simply refers to Aricept tablets.
Both contain donepezil, but each tablet provides a different amount. Treatment usually begins at 5 mg, with an increase considered later.
Other strengths and formulations are described in international references, but their local availability must be checked. They should not be assumed interchangeable with the 10 mg tablets discussed here.
Aricept treats symptoms of dementia associated with mild, moderate or severe Alzheimer’s disease. The degree of benefit differs between individuals.
It is not a general memory supplement or a routine treatment for ordinary forgetfulness. If memory difficulties affect everyday life, book a neurologist for assessment before considering medication.
The usual starting oral dose is 5 mg once daily. A prescriber may increase this to 10 mg once daily after at least 4–6 weeks, depending on response and tolerance.
These are general prescribing details, not instructions for an individual patient. Do not start at 10 mg or increase the dose without medical advice.
Aricept is usually taken in the evening before bedtime. A consistent routine and caregiver supervision can help prevent missed or repeated doses.
Aricept can be taken with or without food. There is no requirement to take it specifically before or after a meal. Follow the prescription and report persistent digestive symptoms.
Skip the missed dose and take the next at the normal time. Do not double the dose. If treatment has stopped for more than seven consecutive days, contact the prescriber before restarting.
Noticeable benefit may take about a month or 4–6 weeks, and sometimes longer. An immediate improvement after the first tablet is not expected.
Follow-up should consider changes in everyday functioning as well as memory. Some people show more improvement than others.
Possible side effects include:
• Nausea, vomiting and diarrhoea.
• Reduced appetite and weight loss.
• Muscle cramps and tiredness.
• Insomnia or unusual dreams.
• Dizziness and occasional drowsiness.
Report symptoms that persist, interfere with eating or drinking, or affect balance. Side effects may be more noticeable when treatment begins or the dose increases.
Seek urgent help for fainting, a very slow heartbeat, seizures, vomiting blood, black stools or serious breathing problems. Swelling of the face or tongue with breathing difficulty may indicate a severe allergic reaction.
Aricept must not be used by someone with known hypersensitivity to donepezil, piperidine derivatives or its ingredients.
Tell the prescriber about heart conduction problems, a slow pulse, stomach ulcers, previous gastrointestinal bleeding, asthma, chronic obstructive pulmonary disease, seizures, urinary difficulty or swallowing problems.
Inform the anaesthetic team before surgery. These conditions need assessment; they are not all absolute contraindications.
The pharmacist should review all medicines and supplements, particularly:
• Aspirin and NSAIDs: these may increase gastrointestinal bleeding concerns.
• Anticholinergic medicines: their effects may oppose donepezil.
• Certain anaesthetic medicines and muscle relaxants: their effects may be enhanced.
• Medicines affecting heart rate or rhythm: compatibility needs review.
Do not stop another prescribed treatment solely because a possible interaction is identified.
Pregnancy safety data are insufficient, so use requires an individual assessment of benefits and risks.
It is unknown whether donepezil passes into human breast milk or how it could affect a nursing infant. Seek specialist advice before use while breastfeeding.
Aricept is normally prescribed daily and may continue long term while the clinician considers its benefits worthwhile.
Reviews should assess daily functioning, treatment tolerance, pulse, appetite and weight. Do not change the dose or stop treatment without consulting the prescriber.
An alternative may be another donepezil product with the correct strength and formulation. Depending on the diagnosis and disease stage, a clinician may consider rivastigmine, galantamine or memantine instead.
These medicines are not interchangeable dose for dose. Suitability and local availability should be checked with the prescriber and pharmacist.
To check the price and order the medicine, visit Aricept 10 mg, 7 tablets on Vezeeta.
Compare the number of tablets per pack and confirm availability for your delivery location.
Drowsiness and dizziness can occur, although insomnia and unusual dreams are also possible. Avoid driving or hazardous activities if alertness or coordination is affected, and report persistent symptoms.
Aricept is not an appetite stimulant or a weight-gain treatment. Reduced appetite and weight loss may occur instead. Monitor weight and seek advice if eating declines or weight loss continues.
No. Aricept is not a painkiller or a standard treatment for peripheral nerve pain. Its established purpose is the treatment of symptoms associated with Alzheimer’s dementia.
Safety and effectiveness have not been established in people under 18. Aricept should not be used to improve school performance, concentration or ordinary memory in children.
Do not start at 10 mg unless specifically instructed by the prescriber. The usual initial dose is 5 mg daily, with an increase considered after at least 4–6 weeks.
An overdose requires urgent medical attention. Signs may include severe vomiting, excessive sweating or saliva, muscle weakness, slow heartbeat, breathing difficulty and seizures. Do not wait for severe symptoms before seeking help.